Advertisement
Home 2017

Archives

From 2013 to 2015 there was a decrease in additional surgery after initial lumpectomy

ASCO: Recent Drop in Additional Surgery Post Lumpectomy

0
Decrease was concomitant with 2014 consensus statement endorsing a margin of no ink on tumor
Two new medications that target specific genetic mutations may improve survival for patients with specific types of advanced non-small-cell lung cancer

ASCO: Novel Meds Show Promise in Advanced NSCLC

0
Results presented from two phase III trials
A new type of immunotherapy appears to provide long-lasting protection against multiple myeloma

ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma

0
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein
Over the past 60 years

ASCO: SWOG Trials Have Had Considerable Impact on Cancer

0
Estimated 3.34 million life-years gained through 2015 from 23 positive SWOG treatment trials
Free meals

ASCO: Industry Perks Influence Physicians’ Choice of Cancer Rx

0
Even relatively small payments appear to make a difference, researchers say
Olaparib (Lynparza) monotherapy can provide a significant benefit over standard therapy in women with human epidermal growth factor receptor type 2-negative metastatic breast cancer and a germline BRCA mutation

ASCO: Olaparib Efficacious in BRCA-Related Breast Cancer

0
May offer a new treatment for women with advanced BRCA-related disease, researchers say
A patient-reported outcome intervention for symptom monitoring is associated with improved overall survival for patients treated with chemotherapy for metastatic solid tumors

ASCO: Survival Up With Patient-Reported Outcomes During CA Tx

0
Improved survival with patient-reported outcomes for symptom monitoring in metastatic cancer
An experimental drug that targets tropomyosin receptor kinase fusion

ASCO: Gene-Targeted Drug Shows Efficacy for Child, Adult Cancers

0
Larotrectinib targets tropomyosin receptor kinase fusion proteins
In men with advanced prostate cancer

ASCO: Abiraterone Extends Survival in Metastatic Prostate CA

0
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
Online cognitive behavior therapy programs can help some people with mild or moderate depression

APA: Internet-Based CBT Can Be Helpful in Depression

0
For people with mild or moderate depression, web-based versions might help, researchers say